|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 701 Pennsylvania Ave. |
Address2 | Ste. 700 |
City | Washington |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 308456-12
|
||||||||
|
6. House ID# 396000000
|
TYPE OF REPORT | 8. Year | 2009 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Tracey A. Moorhead, President & CEO |
Date | 04/20/2009 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Education and support for population-based health programs, such as disease and care management in FFS Medicare and Medicare Advantage, including Special Needs Plans (specifically, the reauthorization of Chronic Care Special Needs Plans, or C-SNPs, the incorporation of reasonable process measures and standards for SNP evaluation, and recommendations for CMS' Chronic Conditions SNP Panel); Medicare pilots and demonstrations such as the Medicare Medical Home Demonstration, Senior Risk Reduction Dem-
onstration, Medicare Physician Group Practice Demonstration, Medicare Electronic Health Records Demonstration, the Medicare Coordinated Care Demonstration (MCCD, as authorized under Section 4016 of the Balanced Budget Act of 1997), and Medicare Health Support (as authorized under Section 721 of the Medicare Prescription Drug, Improvement and Modernization Act (MMA), which created the "Voluntary Chronic Care Improvement Program" now called Medicare Health Support) - specifically, the 18-month Report to Congress on Medicare Health Support. Provision of suggestions and recommendations for consideration of the broader inclusion of coordinated chronic care and health service stakeholder expertise in the feasibility study of a Medicare Chronic Care Practice Research Network demonstration program and in outcomes reporting for comparative effectiveness research (authorized in the Medicare Improvements for Patients and Providers Act of 2008).
Analysis and discussions regarding the expanded hospital re-admission reporting requirements included in Final IPPS & OPPS Rules.
Analysis of Congressional Budget Office reports on health care reform key issues and budget options, and promotion of successful outcomes in population health improvement programs as a component of national reform of care delivery, financing and design, particularly in public sector programs. Promotion of alternative modeling might more fully capture the true costs and savings associated with innovative prevention and treatment techniques in health care. Promotion of consideration of alternative models to assess and adjust risk scores related to the illnesses of beneficiaries in the Medicare program.
Support for funding of prevention and wellness programs and initiatives as provided for in the American Recovery and Reinvestment Act of 2009 as passed by the House and Senate. Support for modifying provisions related to HIPAA Privacy rule and security for personal health information as established in the Health-e Information Technology Act (HITECH Act) as part of the American Recovery & Reinvestment Act (ARRA). Encouragement of efforts to preserve HIPAA provisions permitting exchange of protected health information for care coordination and disease management, efforts to advance health information technology deployment, particularly as it would affect individuals with chronic conditions, including e-prescribing, and the creation of interoperability standards and priority use cases and best practices for technology deployment and promotion in care coordination. Support for the exemption of disease management and care coordination efforts from economic stimulus provision that would have required the HHS Secretary to issue new health care operations rules.
Analysis and submission of comments regarding the Genetic Information Nondiscrimination Act (GINA) and the creation of regulations by the EEOC defining the employer wellness program exception as provided for in GINA. Education regarding effectiveness of chronic condition care and its benefits to Medicaid and other populations via the sharing of published quality improvement studies that reported cost or utilization outcomes from the intervention and which are target clinical conditions relevant for Medicaid programs. Advocacy for priorities of all stakeholders providing services along the care continuum toward the goal of population health improvement in proposed and realized legislation, including S. 3613 & H.R. 7114, the Independence at Home Act of 2008; S. 631 & H.R. 5765, the Remote Monitoring Access Act of 2007; S. 334, the Healthy Americans Act; S. 1340, the Geriatric Assessment and Chronic Care Coordination Act of 2007; S. 1753, the Healthy Workforce Act of 2007; H.R. 3800, the Wired for Healthcare Quality Act; H.R. 6357, Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology PRO(TECH)T Act of 2008; H.R. 6898, the Health-e Information Technology Act of 2008 (HITECH Act); H.R. 5442, TRUST in Health Information Act of 2008; S. 3101, Medicare Improvements for Patients and Providers Act of 2008; S. 3118, Preserving Access to Medicare Act of 2008; H.R. 853, Wellness and Prevention Act of 2007; H.R.6331, Medicare Improvements for Patients and Providers Act of 2008; the Children's Health Insurance Program Reauthorization Act of 2009 (CHIPRA); the American Recovery & Reinvestment Act (ARRA); initiatives pertaining to the treatment and prevention of obesity as a chronic disease generally and as a component of population health improvement approaches to addressing the obesity epidemic.
Advocacy and support for expansion of Medicare-covered clinical preventive services as recommended by the U.S. Preventive Services Task Force and provided for in the Medicare Improvements for Patients and Providers Act of 2008 (MIPPA). Endorsement of the Healthy Workforce Act of 2009 and promotion of the legislation through the Healthy Workplace Alliance. General advocacy for population health improvement as a tool to improve the quality of health care and health care outcomes, and reduce preventable health care costs, and promotion of health promotion, wellness, and care coordination programs at the White House Regional Health Reform Summits.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agency for Health Care Policy & Research, Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tracey |
Moorhead |
|
|
|
Jennifer |
Martin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |